NEW YORK (GenomeWeb News) – Nanogen today said that it will collaborate with Italian firm A. Menarini Diagnostics to sell CE-marked in vitro diagnostic kits based on Nanogen’s MGB technology for infectious diseases.
Nanogen will manufacture the kits, which will be branded as Menarini products and sold by the Italian firm in Europe. The San Diego-based firm did not disclose which infectious diseases the molecular diagnostic test kits will target, but it said products would be introduced to the market in 2009.
Nanogen CEO Hoard Birndorf said in a statement that the firm’s technology combined with Menarini’s local sales strength “will open a new market and revenue stream for Nanogen and will make a highly competitive offering in Europe.”
Further terms of the alliance were not disclosed.